Health in Emergency and Disaster Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Department of Clinical Science and Education, Karolinska Institute, Stockholm, Sweden.
Front Public Health. 2023 Jan 5;10:958899. doi: 10.3389/fpubh.2022.958899. eCollection 2022.
Along with the challenges of COVID-19 vaccine supply in low-income countries, vaccine hesitancy was another problem for the health system. The aim of this study was to deeply understand the challenges of vaccine acceptance, the vaccination process, and to compare the affecting vaccine acceptance in the high and low points of the epidemic in Iran.
In the qualitative part of this mixed-methods study, content analysis was used to investigate experiences and perceptions about COVID-19 vaccination in four groups. In the quantitative study, in March 2021 (low point), and on August 1, 2021 (high point), two population-based cross-sectional studies were performed in Tehran and its rural, with sample sizes of 1,200 and 1,872 people aged over 18 years, respectively. Multinomial (polytomous) logistic regression was used to determine the factors affecting hesitation and unwillingness to receive the vaccine.
Disbelief in vaccine safety, vaccine distrust, ignorance and confusion, and inadequate facilities were the common reasons extracted in the two qualitative studies. At the low and high points of the epidemic, vaccine acceptance was 83.6% (95% CI: 81.3-85.9) and 65.8% (95% CI: 65.8-71.0), respectively. Residence in rural areas, (Odds Ratio: 0.44, = 0.001), being a student (Odds Ratio: 0.41, = 0.011), housewives (Odds Ratio: 0.63, = 0.033), illiteracy (Odds Ratio: 4.44, = 0.001), and having an underlying disease (Odds Ratio: 4.44, = 0.001) were factors affecting on vaccine acceptance.
Counter-intuitively, acceptance did not increase at the peak of epidemic. The presence of obstacles, such as increased distrust in the effectiveness of vaccines due to the occurrence of multiple peaks in different vaccinated countries, as well as the influence of the media, anti-vaccine campaigns, and lack of proper communication about risks caused more hesitation. More investigation to understand how people accept or reject vaccine and its long term consequences is recommended.
随着新冠疫苗在低收入国家供应的挑战,疫苗犹豫也是卫生系统面临的另一个问题。本研究的目的是深入了解疫苗接种的接受程度、接种过程,并比较伊朗疫情高峰期和低峰期对疫苗接种接受度的影响。
在这项混合方法的定性部分中,使用内容分析法调查了四个组中关于 COVID-19 疫苗接种的经验和看法。在定量研究中,2021 年 3 月(低峰期)和 2021 年 8 月 1 日(高峰期),在德黑兰及其农村地区进行了两项基于人群的横断面研究,样本量分别为 1200 人和 1872 名 18 岁以上的人。使用多项(多项式)逻辑回归来确定影响犹豫不决和不愿接种疫苗的因素。
疫苗安全性的不信任、疫苗不信任、无知和困惑以及设施不足是从两项定性研究中提取的共同原因。在疫情的低峰期和高峰期,疫苗接种率分别为 83.6%(95%置信区间:81.3-85.9)和 65.8%(95%置信区间:65.8-71.0)。居住在农村地区(优势比:0.44, = 0.001)、学生(优势比:0.41, = 0.011)、家庭主妇(优势比:0.63, = 0.033)、文盲(优势比:4.44, = 0.001)和患有潜在疾病(优势比:4.44, = 0.001)是影响疫苗接种接受度的因素。
反直觉的是,在疫情高峰期,接受率并没有增加。由于多个高峰在不同接种国家的出现,导致对疫苗有效性的信任度降低,以及媒体、反疫苗运动和缺乏对风险的适当沟通等因素的影响,更多的障碍出现,导致更多的犹豫不决。建议进行更多的调查,以了解人们如何接受或拒绝疫苗及其长期后果。